Back to search
Relapsed Graves' Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsed Graves' Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsed Graves' Disease trials you may qualify forGraves' disease is the most common cause of hyperthyroidism, with conventional treatment options being anti-thyroid drugs (ATD), radioiodine (RAI) and surgery.…
In this study, the dose of methimazole was adjusted according to the different states of thyroid function, and the effects of conventional therapy and intensive…
The main objective of this trial is to assess the efficacy of AMG 732 in participants with thyroid eye disease (TED) who are defined as primary nonresponders or…
This is a Phase 2, double-blind, placebo controlled, Methimazole (MMI) withdrawal study in subjects with Graves' disease. The study consists of up to 5 periods:…